From Drug Benefit News - Marking another key step in the long-awaited arrival of biosimilars to the U.S., Sandoz on July 24 said the FDA accepted biosimilar filgrastim for review. Sandoz, a Novartis Group company, is the first firm to announce a biosimilar filing under the pathway created in the Biologics Price Competition and Innovation Act contained in the health reform law. Read more
From Drug Benefit News - Although CMS dropped its previous proposal to significantly expand medication therapy management (MTM) from the final Medicare Advantage (MA) and Part D rule issued in May, the new plan marketing guidelines released a month later appear to encourage more widespread use of those programs without mandating them. Read more
From Specialty Pharmacy News - Consumer advocacy groups in California and Florida have taken various actions against health plans and their coverage of HIV/AIDS drugs and requirements for members who take them. And while Consumer Watchdog and The AIDS Institute, in conjunction with The National Health Law Program (NHeLP), are taking somewhat different approaches, they are united in the contention that these members are being discriminated against, and the Affordable Care Act (ACA) bans health… Read more
Check out all of the benefits, sample issues & more!